These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 16958834

  • 21. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Peden AH, Ritchie DL, Ironside JW.
    Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
    [Abstract] [Full Text] [Related]

  • 22. Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.
    Pillonel J, Brandel JP, Léon L, Salomon D, Haïk S, Capek I, Vaillant V, Coste J, Alpérovitch A.
    Transfusion; 2012 Jun; 52(6):1290-5. PubMed ID: 22128904
    [Abstract] [Full Text] [Related]

  • 23. Epidemiology of variant CJD.
    Knight R.
    Dev Biol (Basel); 2002 Jun; 108():87-92. PubMed ID: 12220145
    [Abstract] [Full Text] [Related]

  • 24. Blood transfusion and spread of variant Creutzfeldt-Jakob disease.
    Dietz K, Raddatz G, Wallis J, Müller N, Zerr I, Duerr HP, Lefèvre H, Seifried E, Löwer J.
    Emerg Infect Dis; 2007 Jan; 13(1):89-96. PubMed ID: 17370520
    [Abstract] [Full Text] [Related]

  • 25. [Transfusion risk analysis with regard to vCJD in France].
    Martin M, Legras JF, Pouchol E, Trouvin JH.
    Transfus Clin Biol; 2006 Nov; 13(5):298-303. PubMed ID: 17188540
    [Abstract] [Full Text] [Related]

  • 26. Creutzfeldt-Jakob disease and blood transfusion.
    Esmonde TF, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, Matthews WB.
    Lancet; 1993 Jan 23; 341(8839):205-7. PubMed ID: 8093499
    [Abstract] [Full Text] [Related]

  • 27. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan 23; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 28. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
    Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M.
    Neuropathology; 2009 Oct 23; 29(5):625-31. PubMed ID: 19659942
    [Abstract] [Full Text] [Related]

  • 29. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks.
    Pozzo di Borgo A, Rochette S, Gaussen A, O'Brien SF, Germain M, Renaud C, Lewin A.
    Transfus Med Rev; 2023 Jul 23; 37(3):150747. PubMed ID: 37827587
    [Abstract] [Full Text] [Related]

  • 30. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
    Hoots WK, Abrams C, Tankersleydagger D.
    Transfus Med Rev; 2001 Apr 23; 15(2 Suppl 1):45-59. PubMed ID: 11441420
    [Abstract] [Full Text] [Related]

  • 31. Variant Creutzfeldt-Jakob disease.
    Ironside JW.
    Haemophilia; 2010 Jul 23; 16 Suppl 5():175-80. PubMed ID: 20590878
    [Abstract] [Full Text] [Related]

  • 32. Variant CJD. 18 years of research and surveillance.
    Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, Manson JC, Will RG.
    Prion; 2014 Jul 23; 8(4):286-95. PubMed ID: 25495404
    [Abstract] [Full Text] [Related]

  • 33. Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease.
    de Pedro Cuesta J, Ruiz Tovar M, Ward H, Calero M, Smith A, Verduras CA, Pocchiari M, Turner ML, Forland F, Palm D, Will RG.
    Neuroepidemiology; 2012 Jul 23; 39(1):1-18. PubMed ID: 22777385
    [Abstract] [Full Text] [Related]

  • 34. Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia.
    McManus H, Seed CR, Hoad VC, Kiely P, Kaldor JM, Styles CE, Yang H, Law M, Gosbell IB.
    Vox Sang; 2022 Aug 23; 117(8):1016-1026. PubMed ID: 35609012
    [Abstract] [Full Text] [Related]

  • 35. Application of telehealth for comprehensive Creutzfeldt-Jakob disease surveillance in the United Kingdom.
    Watson N, Kurudzhu H, Green A, Summers D, Smith C, Pal S.
    J Neurol Sci; 2021 Jan 15; 420():117221. PubMed ID: 33223148
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.
    Cooper JK, Andrews N, Ladhani K, Bujaki E, Minor PD.
    Vox Sang; 2013 Oct 15; 105(3):196-204. PubMed ID: 23772892
    [Abstract] [Full Text] [Related]

  • 37. Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease (CJD) (or other prion diseases) through medical treatment (iatrogenically).
    Ryan R, Hill S, Lowe D, Allen K, Taylor M, Mead C.
    Cochrane Database Syst Rev; 2011 Mar 16; (3):CD007578. PubMed ID: 21412905
    [Abstract] [Full Text] [Related]

  • 38. Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood.
    Gregori L, Yang H, Anderson S.
    Transfusion; 2011 Dec 16; 51(12):2596-602. PubMed ID: 21645006
    [Abstract] [Full Text] [Related]

  • 39. Variant Creutzfeldt-Jakob disease.
    Will R.
    Folia Neuropathol; 2004 Dec 16; 42 Suppl A():77-83. PubMed ID: 15449462
    [Abstract] [Full Text] [Related]

  • 40. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK, Law MG, Seed CR, Gust A, Buring M, Dax EM, Keller AJ, Kaldor JM.
    Vox Sang; 2001 Jul 16; 81(1):6-11. PubMed ID: 11520409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.